Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression


Autoria(s): SNYDER-CAPPIONE, Jennifer E.; LOO, Christopher P.; CARVALHO, Karina I.; KUYLENSTIERNA, Carlotta; DEEKS, Steven G.; HECHT, Frederick M.; ROSENBERG, Michael G.; SANDBERG, Johan K.; KALLAS, Esper G.; NIXON, Douglas F.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

Objective: Natural killer T (NKT) cells are efficiently targeted by HIV and severely reduced in numbers in the circulation of infected individuals. The functional capacity of the remaining NKT cells in HIV-infected individuals is poorly characterized. This study measured NKT cell cytokine production directly ex vivo and compared these responses with both the disease status and NKT subset distribution of individual patients. Methods: NKT cell frequencies, subsets, and ex-vivo effector functions were measured in the peripheral blood mononuclear cells of HIV-infected patients and healthy controls by flow cytometry. We measured cytokines from NKT cells after stimulation with either a-galactosyl ceramide-loaded CD1d dimers (DimerX-alpha GalCer) or phorbol myristate acetate and ionomycin. Results: The frequencies of NKT cells secreting interferon-gamma and tumor necrosis factor-alpha were significantly lower in HIV-infected patients than healthy controls after DimerX-alpha GalCer treatment, but responses were similar after treatment with phorbol myristate acetate and ionomycin. The magnitude of the interferon-gamma response to DimerX-alpha GalCer correlated inversely with the number of years of infection. Both interferon-gamma and tumor necrosis factor-alpha production in response to DimerX-alpha GalCer correlated inversely with CD161 expression. Conclusion: The ex-vivo Th1 responses of circulating NKT cells to CD1d-glycolipid complexes are impaired in HIV-infected patients. NKT cell functions may be progressively lost over time in HIV infection, and CD161 is implicated in the regulation of NKT cell responsiveness. (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins

NIAID[R37-A152731]

Brazilian Program for STD and AIDS

Ministry of Health[914/BRA/3014 - UNESCO/Kallas]

Sao Paulo City Health Departmen[20040.168.922-7/Kallas]

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)[04/15856-9/Kallas]

John E. Fogarty International Center (FIRCA/NIH)[D43 TW00003]

AIDS Research Institute of the AIDS Biology Program

Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)

Brazilian Ministry of Education

Identificador

AIDS, v.23, n.15, p.1965-1970, 2009

0269-9370

http://producao.usp.br/handle/BDPI/23225

10.1097/QAD.0b013e32832165134

http://dx.doi.org/10.1097/QAD.0b013e32832165134

Idioma(s)

eng

Publicador

LIPPINCOTT WILLIAMS & WILKINS

Relação

AIDS

Direitos

restrictedAccess

Copyright LIPPINCOTT WILLIAMS & WILKINS

Palavras-Chave #CD161 #HIV #interferon-gamma #natural killer T #tumor necrosis factor-alpha #alpha-galactosyl ceramide #INVARIANT NKT CELLS #AIRWAY HYPERREACTIVITY #V-ALPHA-24 #SUBSETS #IL-17 #RECEPTOR #DEFINES #THYMUS #Immunology #Infectious Diseases #Virology
Tipo

article

original article

publishedVersion